This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo
More from medscape

News

Study Suggests a Third of COVID-19 Hospital Patients May Die

A third of patients in hospital with COVID-19 may be dying, according to preliminary UK research.

The preprint also found that being male or obese reduced chances of survival from the disease.

More than half of patients mechanically ventilated are dying, the authors said.

The prospective observational cohort study, which has not been peer reviewed, was carried out by a consortium of researchers, known as ISARIC4C, and was led by the University of Liverpool, University of Edinburgh, and Imperial College London (ICL).

They set out to discover who was most severely affected by the virus, what happens to them in hospital, and why some people have better outcomes than others.

A pre-approved questionnaire adopted by the World Health Organisation was used to gather information in 166 UK hospitals between 6th February and 18th April 2020.

A total of 16,749 people with COVID-19, with a median age of 72, were involved in the research.

Main Findings

Overall, the findings showed that:

  • 49% of patients were discharged alive
  • 33% had died
  • 17% continued to receive care at the date of reporting

Of the 17% of patients admitted to High Dependency or Intensive Care Units because of COVID-19:

  • 31% were discharged alive
  • 45% died
  • 24% continued to receive care at the reporting date

Of patients requiring mechanical ventilation:

  • 20% were discharged alive
  • 53% died
  • 27% remained in hospital

The study also cast light on the role that age and sex might play in patient outcomes.

More men (60.2%) than women (39.8%) had been admitted to hospital with COVID-19.

Only 2.0% of patients admitted to hospital were under 18 years.

Six percent of women of reproductive age were pregnant.

Increased age was a strong predictor of in-hospital mortality.

The Role of Obesity

The research found that after adjusting for other medical problems already known to cause poor outcomes, being obese was a significant factor associated with hospital deaths.

Obesity was recognised as a risk factor in 2009 for pandemic A/H1N1 influenza, the authors write, although not in 2016 Middle East respiratory syndrome coronavirus (MERS-CoV).

They speculate that obese people with COVID-19 could have reduced lung function and possibly more inflammation in adipose tissue, which might contribute to an enhanced 'cytokine storm'.
 

Comorbidities

According to the Department of Health and Social Care, COVID-19 can be more severe in older people and those with chronic heart, lung, and kidney disease, a weakened immune system, diabetes, and some cancers.

The study found that the commonest comorbidities among patients were:

  • Chronic cardiac disease (29%)
  • Uncomplicated diabetes (19%)
  • Non-asthmatic chronic pulmonary disease (19%)
  • Asthma (14%)

However, 47% of patients had no documented comorbidity.

Symptoms

The main symptoms found among patients with COVID-19 were:

  • Respiratory (cough, sputum, sore throat, runny nose, wheeze, and chest pain)
  • Systemic (fever, myalgia, joint pain and fatigue)
  • Enteric (abdominal pain, vomiting and diarrhoea)

Out of 11,326 patients, the most common symptoms were cough (70%), fever (69%), and shortness of breath (65%). Fatigue and confusion also featured quite prominently.

Only 4% of patients reported no symptoms.

Professor Calum Semple, from the University of Liverpool, who led the study, said: "We must do everything humanly possible to understand this disease, so that we are better prepared for the next wave of this pandemic."

Professor Peter Openshaw, from the National Heart & Lung Institute at ICL, said: "Our research provides an exceptional picture of the illness and risk factors and will underpin a huge range of research."

'Helpful Insights'

Derek Hill, professor of medical imaging at University College London, described the research as "extremely impressive".

He told the Science Media Centre: "This is an especially large study so it provides helpful insights into the symptoms of COVID-19 patients admitted to hospital.  

"As has been reported many times, this is not like flu in who gets seriously ill or in mortality: young children seem to have low risk and pregnant women do not have a increased risk of serious illness, and it is deadlier than flu.  

"There are several distinctive clusters of symptoms, with a significant number of patients not having the characteristic cough and fever symptoms. If extrapolated to the community this might suggest some deaths due to COVID-19 might be missed in untested people.  

"This work also highlights the link between obesity and poor outcome from COVID-19."

Prof Hill pointed out that the findings only cover people with COVID-19 who were admitted to hospital.

Also, many people are still undergoing treatment, and so mortality and survival figures might change.

Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol, doi: https://doi.org/10.1101/2020.04.23.20076042 Paper

Register Today

Already a member? Log in

YOU MAY ALSO LIKE

Low-dose inhaled corticosteroids and formoterol combination now recommended for newly diagnosed patients aged 12 or over instead of short-acting beta2 agonist inhaler.
Patients prescribed antipsychotics without psychiatric oversight or cardiometabolic monitoring.
In 'reassuring' findings, children with the skin disease reached various pubertal milestones at almost the same ages as unaffected peers.
University Hospitals Sussex NHS Foundation Trust was responsible for 21.4% of the total waiting for at least a year and a half for pre-planned hospital treatment.
Nutritious meals are a crucial aspect of recovery for hospitalised patients, but financial pressures have led many hospitals to cut back on high-quality foods.
A recent analysis suggested improved survival for women screened for breast cancer at ages 40-49, whereas draft guidelines state the harms could outweigh the benefits.
Studies have found age can be a determining factor that dictates the treatment received. With Europeans living longer, doctors need to improve their attitudes towards ageing.
NICE recommended monthly injections of eplontersen at home for adults with hereditary transthyretin-mediated amyloidosis and stage 1 or stage 2 polyneuropathy.
MPs vote tomorrow whether a bill to legalise assisted dying in the UK should progress through parliament.
Menopause before age 40 years increased the risk by nearly 50% when compared with menopause in the average age range.
The Swiss HIV National Cohort findings challenged guidelines on low-level viremia.
A randomised phase 3 trial in patients with low-risk differentiated thyroid cancer showed no outcome difference at 5 years.
It comes as figures showed there were now more doctors from an ethnic minority background on the register than white doctors.
While tapering corticosteroids can reduce infections and hospitalizations for patients with severe alcohol-associated hepatitis, it may not affect survival outcomes.
The former head of a French hospital's emergency department explained why patients were transferred to a nearby garage during times of overcrowding.
A clinical trial examined benralizumab, a monoclonal antibody that targets eosinophils to reduce lung inflammation.
Of 3000 men who visited at various London sites, 16% of attendees and 22% of those diagnosed with prostate cancer were Black.
Reframe challenges and lighten the burden. Discover how coaching provides physicians with a low-pressure way to explore solutions and shift their mindset.
Covers NICE, BTS, and SIGN’s joint recommendations on diagnosing, monitoring, and managing asthma in adults, young people, and children
The analysis, which compared two tumor necrosis factor inhibitors, is believed to be the first of its kind.